Osteoarthritis: Not Just an Old Dog Disease (Advertorial)

When you think of osteoarthritis (OA), “old,” “senior,” or “geriatric” dogs likely come to mind. But a recent study reveals a surprising truth: OA isn’t just a disease of old age. In fact, 40% of dogs under 4 years showed radiographic signs of OA, and 25% of those were already in pain (Enomoto et al., 2024).

This finding is a wake-up call for clinicians and pet owners—OA can begin early, and its impact can be significant if left unaddressed.

Early-Onset OA: The Risk Factors

The onset of OA in younger dogs is often due to:

• Genetics – Breeds predisposed to dysplasia or joint issues
• Trauma – Previous injuries can accelerate joint deterioration
• Obesity – Added weight increases stress on developing joints
• Orthopaedic Disease – Conditions like luxating patella or cruciate injuries
• Lifestyle – High-impact or repetitive activity patterns

These risk factors make a strong case for shifting from reactive to proactive joint care—starting well before visible signs appear.

Why Early Intervention Matters

OA is a progressive disease. Once clinical signs like stiffness or lameness show, significant joint damage may already be present. Early intervention helps slow progression, protect joint structures, and extend quality of life.

As awareness of long-term joint care grows, Antinol® is increasingly recognised as a clinically proven, natural therapeutic—ideal for early intervention in young dogs and ongoing management in seniors. Its strong safety profile and compatibility with multimodal treatment make it a trusted choice across all life stages.

Antinol®: The go-to nutritional support for early joint health management

When it comes to safe, proactive support, Antinol® stands out:

• Clinically Proven – Backed by over 15 independent, peer-reviewed studies
• Safe for Long-Term Use – With minimal side effects, even in dogs with comorbidities
• Powerful Blend – EAB-277™ combines green-lipped mussel oil + krill oil for over 90 fatty acids, including ETA
• Superior Absorption – Its phospholipid base ensures fast, effective bioavailability
• Multimodal Compatibility – Can be used alongside NSAIDs or other therapies
• Ease of Use – Palatable and easy to administer daily

Antinol® supports  joint function and mobility, especially in at-risk or aging dogs.

Why Choose Antinol® Early?

As concern grows around over-reliance on medications, more vets and pet owners are looking for effective, natural alternatives. Antinol® delivers a safe, science-backed solution that supports joint health from the inside out—without waiting for symptoms to worsen.

It’s not just a supplement—it’s part of a proactive joint care plan, keeping dogs mobile, active, and doing what they love for longer.

Discover how Antinol® can support your patients at every stage — visit antinol.com.au

Reference

Enomoto, M., de Castro, N., Hash, J., Thomson, A., Nakanishi-Hester, A., Perry, E., Aker, S., Haupt, E., Opperman, L., Roe, S. and Cole, T., 2024. Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs. Scientific Reports, 14(1), p.2827.